CNBX PHARMACEUTICALS INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-05-31 was $28.00K, a 69.83% decline year-over-year.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-02-28 was $83.52K, a 512.32% increase year-over-year.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-11-30 was $37.04K.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-08-31 was $191.22K.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $297.66K, a 220.80% increase from fiscal 2024.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $92.79K, a 83.72% decline from fiscal 2023.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $569.93K, a 152.98% increase from fiscal 2022.
- CNBX PHARMACEUTICALS INC. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $225.29K, a 86.06% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-05-31 | $28.00K 10-Q · filed 2026-06-24 | $339.78K derived: sum of 4 quarters · filed 2026-06-24 |
| 2026-02-28 | $83.52K 10-Q · filed 2026-04-14 | $404.58K derived: sum of 4 quarters · filed 2026-06-24 |
| 2025-11-30 | $37.04K 10-Q · filed 2026-01-14 | $334.70K derived: sum of 4 quarters · filed 2026-06-24 |
| 2025-08-31 | $191.22K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-01 | $297.66K 10-K · filed 2025-12-01 |
| 2025-05-31 | $92.80K 10-Q · filed 2026-06-24 | |
| 2025-02-28 | $13.64K 10-Q · filed 2025-04-14 | |
| 2024-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-01 | $92.79K 10-K · filed 2025-12-01 |
| 2024-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-07-14 | $192.59K derived: sum of 4 quarters · filed 2025-07-14 |
| 2024-02-29 | $26.88K 10-Q · filed 2025-04-14 | $414.39K derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-11-30 | $65.91K 10-Q · filed 2025-01-13 | $635.84K derived: sum of 4 quarters · filed 2025-01-13 |
| 2023-08-31 | $99.80K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-29 | $569.93K 10-K · filed 2024-11-29 |
| 2023-05-31 | $221.80K 10-Q · filed 2024-07-15 | |
| 2023-02-28 | $248.33K 10-Q · filed 2024-04-16 | |
| 2022-08-31 | -$3.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-30 | $225.29K 10-K · filed 2023-11-30 |
| 2022-05-31 | $2.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14 | |
| 2022-02-28 | $50.00K 10-Q · filed 2023-04-14 | |
| 2021-08-31 | $275.76K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-30 | $1.62M 10-K · filed 2022-11-30 |
| 2021-05-31 | $1.34M 10-Q · filed 2022-07-14 | |
| 2016-08-31 | $21.93K 10-K · filed 2017-12-08 | |
| 2014-08-31 | $100.00K 10-K · filed 2016-01-07 |